Non melanoma skin cancer and subsequent cancer risk

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Rees, Judy R ^a,b   Zens, M Scot ^a   Gui, Jiang ^a   Celaya, Maria O ^a,b   Riddle, Bruce L ^a,b   Karagas, Margaret R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b New Hampshire State Cancer Registry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON MELANOMA SKIN CANCER; PROSTATE CANCER; RISK FACTOR; SKIN CANCER; SKIN SENSITIVITY; SMOKING; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; SUNLIGHT; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CASE CONTROL STUDY; FOLLOW UP; MELANOMA; NEOPLASMS, SECOND PRIMARY; PROPORTIONAL HAZARDS MODEL; RISK; SKIN NEOPLASMS;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; NEOPLASMS, SECOND PRIMARY; PROPORTIONAL HAZARDS MODELS; RISK; SKIN NEOPLASMS;

EID: 84903281207     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099674     Document Type: Article

References (46)

1. Weinstock MA (1993) Nonmelanoma skin cancer mortality in the United States, 1969 through 1988. Arch Dermatol 129: 1286-1290. (Pubitemid 23296739)
2. Athas WF, Hunt WC, Key CR (2003) Changes in nonmelanoma skin cancer incidence between 1977-1978 and 1998-1999 in Northcentral New Mexico. Cancer Epidemiol Biomarkers Prev 12: 1105-1108. (Pubitemid 37310271)
3. Kaldor J, Shugg D, Young B, Dwyer T, Wang YG (1993) Non-melanoma skin cancer: ten years of cancer-registry-based surveillance. Int J Cancer 53: 886-891. (Pubitemid 23119530)
4. Karagas MR, Greenberg ER, Spencer SK, Stukel TA, Mott LA (1999) Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer 81: 555-559. (Pubitemid 29203052)
5. Bower CP, Lear JT, Bygrave S, Etherington D, Harvey I, et al. (2000) Basal cell carcinoma and risk of subsequent malignancies: A cancer registry-based study in southwest England. J Am Acad Dermatol 42: 988-991. (Pubitemid 30368666)
6. Brewster AM, Alberg AJ, Strickland PT, Hoffman SC, Helzlsouer K (2004) XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 13: 1271-1275. (Pubitemid 39071548)
7. Crocetti E, Carli P (2004) Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients. Eur J Cancer Prev 13: 33-37. (Pubitemid 38328117)
8. Efird JT, Friedman GD, Habel L, Tekawa IS, Nelson LM (2002) Risk of subsequent cancer following invasive or in situ squamous cell skin cancer. Ann Epidemiol 12: 469-475.
9. Friedman GD, Tekawa IS (2000) Association of basal cell skin cancers with other cancers (United States). Cancer Causes Control 11: 891-897. (Pubitemid 32005300)
10. Frisch M, Hjalgrim H, Olsen JH, Melbye M (1996) Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med 125: 815-821. (Pubitemid 126449719)
11. Hemminki K, Dong C (2000) Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin. Arch Dermatol 136: 647-651. (Pubitemid 30304946)
12. Hemminki K, Aaltonen L, Li X (2003) Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma. Cancer 97: 2432-2439. (Pubitemid 36542482)
13. Jung GW, Dover DC, Salopek TG (2014) Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009. Br J Dermatol 170: 136-143.
14. Karagas MR, Greenberg ER, Mott LA, Baron JA, Ernster VL (1998) Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer. Cancer Epidemiol Biomarkers Prev 7: 157-161. (Pubitemid 28109848)
15. Levi F, Randimbison L, La Vecchia C, Erler G, Te VC (1997) Incidence of invasive cancers following squamous cell skin cancer. Am J Epidemiol 146: 734-739. (Pubitemid 27484007)
16. Levi F, Randimbison L, Te VC, La Vecchia C (1996) Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 74: 1847-1850. (Pubitemid 26401911)
17. Lindelof B, Sigurgeirsson B, Wallberg P, Eklund G (1991) Occurrence of other malignancies in 1973 patients with basal cell carcinoma. J Am Acad Dermatol 25: 245-248.
18. Maitra SK, Gallo H, Rowland-Payne C, Robinson D, Moller H (2005) Second primary cancers in patients with squamous cell carcinoma of the skin. Br J Cancer 92: 570-571. (Pubitemid 40395539)
19. Milan T, Pukkala E, Verkasalo PK, Kaprio J, Jansen CT, et al. (2000) Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995. Int J Cancer 87: 283-288. (Pubitemid 30434359)
20. Nugent Z, Demers AA, Wiseman MC, Mihalcioiu C, Kliewer EV (2005) Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 14: 2584-2590. (Pubitemid 41752719)
21. Ong EL, Goldacre R, Hoang U, Sinclair R, Goldacre M (2014) Subsequent primary malignancies in patients with nonmelanoma skin cancer in England: a national record-linkage study. Cancer Epidemiol Biomarkers Prev 23: 490-498.
22. Roh MR, Shin HJ, Lee SH, Chung KY (2012) Risk of second cancers after the diagnosis of non-melanoma skin cancer in Korean patients. J Dermatol 39: 541-544.
23. Rosenberg CA, Greenland P, Khandekar J, Loar A, Ascensao J, et al. (2004) Association of nonmelanoma skin cancer with second malignancy. Cancer 100: 130-138.
24. Song F, Qureshi AA, Giovannucci EL, Fuchs CS, Chen WY, et al. (2013) Risk of a second primary cancer after non-melanoma skin cancer in white men and women: a prospective cohort study. PLoS Medicine 10: e1001433.
25. Teppo L, Pukkala E, Saxen E (1985) Multiple cancer - an epidemiologic exercise in Finland. J Natl Cancer Inst 75: 207-217. (Pubitemid 15229326)
26. Troyanova P, Danon S, Ivanova T (2002) Nonmelanoma skin cancers and risk of subsequent malignancies: a cancer registry-based study in Bulgaria. Neoplasma 49: 81-85. (Pubitemid 34493665)
27. Wassberg C, Thorn M, Yuen J, Ringborg U, Hakulinen T (1999) Second primary cancers in patients with squamous cell carcinoma of the skin: a population-based study in Sweden. Int J Cancer 80: 511-515. (Pubitemid 29047513)
28. Wassberg C, Thorn M, Yuen J, Ringborg U, Hakulinen T (1996) Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden. Br J Cancer 73: 255-259. (Pubitemid 26028343)
29. Wheless L, Black J, Alberg AJ (2010) Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review. Cancer Epidemiol Biomarkers Prev 19: 1686-1695.
30. Chen J, Ruczinski I, Jorgensen TJ, Yenokyan G, Yao Y, et al. (2008) Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst 100: 1215-1222.
31. Robinson SN, Zens MS, Perry AE, Spencer SK, Duell EJ, et al. (2013) Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study. J Invest Dermatol 133: 1950-1955.
32. Havener LE (2004) Standards for Cancer Registries Volume III: Standards for Completeness, Quality, Analysis, and Management of Data. Springfield (IL): North American Association of Central Cancer Registries.
33. Bergmann MM, Calle EE, Mervis CA, Miracle-McMahill HL, Thun MJ, et al. (1998) Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries. Am J Epidemiol 147: 556-562. (Pubitemid 28134242)
34. Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, et al. (1986) Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 123: 894-900. (Pubitemid 16049247)
35. Centers for Disease Control and Prevention (2013) Available: http://www.cdc.gov/cancer/npcr/tools/registryplus/lp.htm.Accessed 2013 Dec.
36. Thornton M, editor (2011) Standards for Cancer Registries. North American Association of Central Cancer Registries. Springfield, Ill.
37. Greenland S (1989) Modeling and variable selection in epidemiologic analysis. Am J Public Health 79: 340-349.
38. Jorgensen TJ, Ruczinski I, Yao Shugart Y, Wheless L, Berthier Schaad Y, et al. (2012) A population-based study of hedgehog pathway gene variants in relation to the dual risk of basal cell carcinoma plus another cancer. Cancer Epidemiol 36: e288-293.
39. Ruczinski I, Jorgensen TJ, Shugart YY, Schaad YB, Kessing B, et al. (2012) A population-based study of DNA repair gene variants in relation to nonmelanoma skin cancer as a marker of a cancer-prone phenotype. Carcinogenesis 33: 1692-1698.
40. Hemminki K, Dong C (2000) Familial relationships in squamous cell carcinoma of the skin. Epidemiology 11: 309-314. (Pubitemid 30228200)
41. Frisch M, Melbye M (1995) New primary cancers after squamous cell skin cancer. Am J Epidemiol 141: 916-922.
42. Hsu LI, Chen GS, Lee CH, Yang TY, Chen YH, et al. (2013) Use of arsenic-induced palmoplantar hyperkeratosis and skin cancers to predict risk of subsequent internal malignancy. Am J Epidemiol 177: 202-212.
43. Cho E, Rosner BA, Colditz GA. (2005) Risk factors for melanoma by body site. Cancer Epidemiol Biomarkers Prev 14: 1241-1244. (Pubitemid 40656474)
44. Thompson CA, Zhang ZF, Arah OA (2013) Competing risk bias to explain the inverse relationship between smoking and malignant melanoma. Eur J Epidemiol 28: 557-567.
45. Walls AC, Han J, Li T, Qureshi AA (2013) Host Risk Factors, Ultraviolet Index of Residence, and Incident Malignant Melanoma In Situ Among US Women and Men. Am J Epidemiol. 177: 997-1005.
46. US Cancer Statistics Working Group. United States Cancer Statistics: 1999-2007 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute (2010) Available: http://apps.nccd.cdc.gov/uscs/. Accessed 2013 Nov.